Want to join the conversation?
$REGN said in full-year 2016 it expects EYLEA US net product sales to be up 20-25% over 2015. Sanofi reimbursement of Regeneron commercialization-related expenses are expected to be $320-370MM in 2016. CapEx is expected to be in the range of $550-625MM, down from the previous range of $580-680MM.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.